Search
for
Sort by
Research 181–210 of 1000+
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Teriflunomida and hair disorders
- Targeting nonmelanoma skin cancer using selective photothermolysis with 595 nm pulsed dye laser: Outcomes of 1080 cases
- Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy
- Tumor Necrosis Factor in Sepsis
- Cutaneous drug reactions
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Alopecia.
- FOX FORDYCE DISEASE IN A PREPUBERTAL GIRL
- GEOGRAPHIC TONGUE IN TWO CHILDREN WITH NONPUSTULAR PSORIASIS
- CUTANEOUS MASTOCYTOSIS IN CHILDREN: AN INDIAN EXPERIENCE
- Antihelminthic Drugs
- PRESEPTAL CELLULITIS DUE TO IMPETIGO – A CASE REPORT OF UNCOMMON PRESENTATION IN PAKISTAN
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- IMPACTOS CAPILARES DA COVID-19 A LIGAÇÃO ENTRE EFLÚVIO TELÓGENO AGUDO E ALOPECIA AREATA: REVISÃO INTEGRATIVA
- Treatment of invasive aspergillosis with itraconazole
- Prostaglandin-Induced Hair Growth
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- How to diagnose a lipodystrophy syndrome
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Hypersensitivity Reactions to Anticoagulant Drugs
- What can the hair tell us about COVID‐19?
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Acne
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Acne